| JXSB2100030 | GSK3511294注射液 | depemokimab | Injection | Biological Products(1) | Supplementary Application | 2021-04-02 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-04-02 | view |
| JXHL2100101 | Linerixibat片 | linerixibat | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-03-24 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-03-23 | view |
| JYHB2100202 | 注射用头孢他啶 | ceftazidime | Lyophilized | Chemical Drugs | Supplementary Application | 2021-03-20 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-03-19 | view |
| JYHZ2100050 | 拉莫三嗪片 | lamotrigine | Tablet | Chemical Drugs | License Renew | 2021-03-11 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-10-19 | view |
| JYHZ2100051 | 拉莫三嗪片 | lamotrigine | Tablet | Chemical Drugs | License Renew | 2021-03-11 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-10-19 | view |
| JYHB2100178 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | Supplementary Application | 2021-03-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-03-05 | view |
| JYHB2100174 | 度他雄胺软胶囊 | dutasteride | Soft capsules | Chemical Drugs | Supplementary Application | 2021-03-04 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-12-14 | view |
| JYSB2100055 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2021-02-23 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-22 | view |
| JYSB2100054 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2021-02-23 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-22 | view |
| JYSB2100057 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2021-02-23 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-22 | view |
| JYSB2100056 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2021-02-23 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-22 | view |
| JYHB2100134 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2021-02-09 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-08 | view |
| JYHB2100135 | 甲苯磺酸拉帕替尼片 | lapatinib ditosylate | Tablet | Chemical Drugs | Supplementary Application | 2021-02-09 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-08 | view |
| JYHB2100129 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2021-02-06 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-05 | view |
| JYHB2100122 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2021-02-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-05 | view |
| JYHB2100121 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2021-02-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-05 | view |
| JYHB2100126 | 沙美特罗替卡松吸入粉雾剂 | fluticasone propionate;salmeterol xinafoate | Inhalation | Chemical Drugs | Supplementary Application | 2021-02-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-05 | view |
| JYHB2100120 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2021-02-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-05 | view |
| JYHB2100125 | 沙美特罗替卡松吸入粉雾剂 | fluticasone propionate;salmeterol xinafoate | Inhalation | Chemical Drugs | Supplementary Application | 2021-02-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-05 | view |
| JYHB2100124 | 沙美特罗替卡松吸入粉雾剂 | fluticasone propionate;salmeterol xinafoate | Inhalation | Chemical Drugs | Supplementary Application | 2021-02-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-05 | view |
